Advancing frailty assessment in dermatology: the role of the Clinical Frailty Scale and multidisciplinary collaboration

ALTUNIŞIK N.

Clinical and Experimental Dermatology, cilt.51, sa.3, ss.489, 2026 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 51 Sayı: 3
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1093/ced/llaf504
  • Dergi Adı: Clinical and Experimental Dermatology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.489
  • İnönü Üniversitesi Adresli: Evet

Özet

I read with great interest the recent letter by Datlı Yakaryilmaz and Turkmen entitled ‘Looking beyond chronological age: the importance of frailty in biologic treatment efficacy in older individuals’. Their emphasis on moving beyond chronological age and considering the phenomenon of frailty when evaluating the efficacy and safety of biologic treatments in older patients with psoriasis is highly valuable.